SINCE 2017

Our products have won high praise from many of  our clients.

KYinno is a biotechnology company dedicated to oncology drug discovery and customised

product development. With a focus on immune therapies against cancer and next-generation

kinase inhibitor discovery, we have collaborated with many researchers from different countries.

Our service platforms include:

Engineered custom cell line development
Cell-based assay validation and compound screening
Phage display library and hybridoma technology for antibody drug conjugate discovery
Cancer cell panel compound profiling and biomarker discovery

Our products include:

Engineered reporter cell lines
Antibody and proteins with fully validated functions in reporter cell lines

Our team members have years of experience in the pharmaceutical and biotechnology industry in both China and U.S.